Connect with us

Business

CSL (ASX:CSL) share price wobbles on COVID vaccine news

Published

on

The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.

The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ) COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.

At the time of writing, the CSL share price is trading flat around $263 as Australian investors digest the news out of the UK.

What’s driving the CSL share price?

The Medicines and Healthcare products Regulatory Agency (MHRA)…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

3 fantastic ASX shares to buy this month
Article feature image
Lithium boom 2.0 drives $4b merger, supply push – The Australian Financial Review